十一月 2025
- Home
- Sorrento Therapeutics
十一月 2025的Sorrento Therapeutics市场份额分析
COOKIE POLICY This Cookie Policy describes how explains how Sorrento Therapeutics, Inc. and its affiliates and subsidiaries (collectively, “Sorrento,” “us,” “we,” or “our”) use cookies and similar technologies in connection with the websites, applications, and portals we operate that link to this Cookie Policy (collectively, the “Site”) to provide, improve, promote, and protect the Site […]
显示 Sorrento Therapeutics 主网站(包括公司地区网站)的流量和参与度信息
查看更多网站流量和参与度信息- sorrentotherapeutics.com
- levenabiopharma.com
Sorrento Therapeutics收入截至 十一月 2025为 50M - 75M
Sorrento Therapeutics主要域名产生的收入
3 年中Sorrento Therapeutics主要域名的收入
Sorrento Therapeutics主要域名的收入
Sorrento Therapeutics热门域名的总访问量
了解Sorrento Therapeutics市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Sorrento Therapeutics热门域名的平均访问时长
分析Sorrento Therapeutics参与度指标。
过去 3 个月的平均访问时长
子公司明细
Sorrento Therapeutics热门域名的平均页面浏览量
了解Sorrento Therapeutics如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Sorrento Therapeutics 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Sorrento Therapeutics, Inc. has issues with securities fraud suit.The U.S. Court of Appeals for the Ninth Circuit dismissed a securities fraud suit against biopharmaceutical company Sorrento Therapeutics, concluding its claims that it found a "cure" for COVID-19, which led to a spike in stock prices, wasn't materially false or misleading.
三月 27, 2024阅读更多
新闻Sorrento Therapeutics, Inc. launched Offering to Dividend Short Holders on Jul 27th '23.Sorrento announces launch of voluntary Offering to Dividend Short Holders with deadline to participate by July 27, 2023.
七月 20, 2023阅读更多
新闻Sorrento Therapeutics, Inc. launches positive findings from a phase IIa study conducted in China on Abivertinib.Sorrento Therapeutics, Inc. (OTC: SRNEQ) has released positive findings from a phase IIa study conducted in China on Abivertinib, a dual inhibitor targeting mutant EGFR and BTK.
七月 5, 2023阅读更多
查看 Sorrento Therapeutics 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。